NDRA (ENDRA Life Sciences) Buyback Yield %: -93.05 (As of Jul. 09, 2026)


NDRA ENDRA Life Sciences Inc NDRA
22 GF Score
Price $4.85
! 2 Warning Signs
View Full Analysis

What is ENDRA Life Sciences Buyback Yield %?

ENDRA Life Sciences NDRA -3.84% 22 Buyback Yield % is -93.05 as of Jul. 09, 2026. GuruFocus rates NDRA with a GF Score™ of 22/100. The stock has 2 warning signs investors should review. Among 91 Medical Diagnostics & Research companies, ENDRA Life Sciences ranks worse than 96.7% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

ENDRA Life Sciences's current buyback yield was -93.05%.

ENDRA Life Sciences Buyback Yield % Historical Data

* Premium members only.

The historical data trend for ENDRA Life Sciences's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ENDRA Life Sciences Buyback Yield % Chart

ENDRA Life Sciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -43.84 -58.97 -29.12 -193.86 -107.62

ENDRA Life Sciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -270.94 -241.37 -153.99 -107.62 -101.38

NDRA vs BIAF, ADVB, MBAI: Buyback Yield % Comparison

For the Diagnostics & Research subindustry, ENDRA Life Sciences's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ENDRA Life Sciences Buyback Yield % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, ENDRA Life Sciences's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where ENDRA Life Sciences's Buyback Yield % falls into.


NDRA
22GF Score
ENDRA Life Sciences Inc NDRA
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ENDRA Life Sciences Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

ENDRA Life Sciences's Buyback Yield for the fiscal year that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 5.733) / 5.32728
=-107.62%

ENDRA Life Sciences's annualized Buyback Yield for the quarter that ended in Mar. 2026 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 5.85) / 5.77065
=-101.38%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of -93.05 mean?
ENDRA Life Sciences (NDRA) has a Buyback Yield % of -93.05 as of Jul. 09, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on ENDRA Life Sciences and its competitors. According to the industry distribution chart, ENDRA Life Sciences ranks #88 out of 91 companies in the Medical Diagnostics & Research industry, placing it in the top 96.7%.
Is ENDRA Life Sciences' Buyback Yield % too high?
ENDRA Life Sciences' current Buyback Yield % is -93.05. Based on the distribution chart, ENDRA Life Sciences ranks #88 out of 91 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, ENDRA Life Sciences has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does ENDRA Life Sciences' Buyback Yield % compare to BIAF and ADVB?
According to the Medical Diagnostics & Research industry distribution chart, ENDRA Life Sciences ranks #88 out of 91 companies for Buyback Yield %. This places ENDRA Life Sciences in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Medical Diagnostics & Research company?
A good Buyback Yield % depends on the Medical Diagnostics & Research industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on ENDRA Life Sciences and its competitors. ENDRA Life Sciences's current Buyback Yield % is -93.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ENDRA Life Sciences stock overvalued right now?
ENDRA Life Sciences (NDRA) has a current Buyback Yield % of -93.05. The current Buyback Yield % is -93.05. ENDRA Life Sciences' overall GF Score™ is 22/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For ENDRA Life Sciences (NDRA), the current Buyback Yield % is -93.05 as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ENDRA Life Sciences Business Description

Address 3600 Green Court, Suite 350, Ann Arbor, MI, USA, 48105-1570
ENDRA Life Sciences Inc is engaged in the development of thermo-acoustic enhanced ultrasound (TAEUS) technology to improve the capabilities of clinical diagnostic ultrasound. The company's technology is used to measure tissue composition, including the assessment of fat in the liver, and is being developed for additional clinical applications such as tissue temperature monitoring.
22GF Score

Get the complete analysis for NDRA

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.85
Price